In silico repurposed drugs against monkeypox virus
Monkeypox is an emerging epidemic of concern. The disease is caused by the monkeypox virus and an increasing global incidence with a 2022 outbreak that has spread to Europe amid the COVID-19 pandemic. The new outbreak is associated with novel, previously undiscovered mutations and variants. Currentl...
Saved in:
Main Authors: | Lam, Hilbert Yuen In, Guan, Jia Sheng, Mu, Yuguang |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Article |
Language: | English |
Published: |
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/167020 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Imported monkeypox, Singapore
by: Yong, Sarah Ee Fang, et al.
Published: (2021) -
What does the anesthesiologist need to know about monkeypox?
by: Teo, Chao Tong, et al.
Published: (2023) -
In silico analyses for the discovery of tuberculosis drug targets
by: Chung, B.K.-S., et al.
Published: (2014) -
Synthesis, biological evaluation and in silico and in vitro mode-of-action analysis of novel dihydropyrimidones targeting PPAR-γ
by: Bharathkumar, H, et al.
Published: (2020) -
Visceral adipose tissue molecular networks and regulatory microRNA in pediatric obesity: an in silico approach
by: Roy, Dipayan, et al.
Published: (2023)